We wanted to reassure you that Arizona Oncology remains open to provide medically necessary, life-sustaining care. In addition, our expert care team can now see patients through scheduled virtual appointments on a secure platform from the comfort and safety of your home.

Please note; only one caregiver is allowed to accompany during your appointment, no one under the age of 18, and no visitors in the infusion rooms, radiation and treatment areas. If you have flu-like symptoms, you should contact Arizona Oncology before visiting our clinics for scheduled appointments. This includes fever and symptoms of respiratory illness, such as coughing or difficulty breathing.
We ask that you follow our tips to stay healthy and to help do our part in prevention of spreading of these viruses.

Locations and Physicians

Govardhanan Nagaiah MD, MS

Patient Portal Genetic Testing


Medical Oncology & Hematology


Glendale - Saguaro Cancer Center
7200 W. Bell Road, Building A
Glendale, AZ 85308
Phone: (623) 487-4822
Fax: (623) 334-9881

Goodyear - Medical Oncology & Hematology, Gynecologic Oncology
13555 W. McDowell Rd., Suite 206
Goodyear, AZ 85395
Phone: 623-469-4222
Fax: 623-535-7367

Govardhanan Nagaiah, MD, MS

Medical School

MGR Medical University,Chennai, India


Mercy Catholic Medical Center,Darby, (Philadelphia) PA


Mercy Catholic Medical Center, Darby, (Philadelphia) PA and National Health Service, United Kingdom


West Virginia University, Morgantown, WV

Board Certification

Dr. Nagaiah is board certified in medical oncology and hematology.




I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide, evidence based care that is appropriate to my patients particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care including alternative therapies that have been shown to be effective.

Academic Honors & Professional Achievements

Masters in Clinical Research: MGH Institute of Health Professions, Boston


1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol. 2011;2011:542358.

2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther. 2011;11(8):1277-1282.

3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228

4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.

5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053